discuss serena williams' glp-1 partnership Williams is returning to tennis — and bringing the debate with her Serena Williams discusses GLP-1 use

Despite the elevated heart rate, cardiovascular outcome trials have shown net cardiovascular benefits, suggesting that the modest chronotropic effect is outweighed by other protective mechanisms

A temperature indicator inside the cooler confirms medication stayed between 40-45F for the entire journey

Her language focused less on numbers and more on overall balance

However, tailoring therapy based on the specific comorbidities can maximize therapeutic benefits rather than addressing each condition separately ( Type 2 diabetes, a common obesity-related comorbidity, significantly improves with weight loss of at least 15% ( Cardiovascular disease is another major obesity-related comorbidity